ACEA Biosciences to be Acquired by Agilent Technologies – Cell Analysis Just Got Better!

VIVIAN CAO SEPTEMBER 26, 2018 ACEA Biosciences announced today that it has signed a definitive agreement to join Agilent Technologies, Inc. (NYSE: A).   ACEA Biosciences is a company known for developing highly innovative products, which are used in academia, as well as the biotech and pharmaceutical industries.  In recent years, the ACEA xCELLigence® RTCA technology has... Read more

Game Changing Tuberculosis Assay Validated for Illumina’s MiSeq® Platform

Next Generation Sequencing (NGS) Kit to Improve Speed and Accuracy of M. Tuberculosis (MTB) Drug Sensitivity Testing (DST) at a Fraction of the Current Cost of Sequencing BETHESDA, Maryland, Sept. 25, 2018 /PRNewswire/ — Longhorn Vaccines and Diagnostics LLC (LHNVD), a private pre-analytical systems and molecular solutions company, is pleased to announce the validation of its newest technology,... Read more

Heathrow Scientific Introduces the MagFuge®, a First-of-its-Kind High-speed Centrifuge and Magnetic Stirrer in One Unit, to its Laboratory Equipment Line

Erin Hankforth Director of Marketing Ph: 847-968-5991 E-mail: ehankforth@heatsci.com www.heathrowscientific.com http://www.heathrowscientific.com/ Vernon Hills, IL, September 25, 2018 – Heathrow Scientific, a leader in manufacturing bench top equipment and lab essentials for scientific and clinical markets announces the introduction of the MagFuge®, a first-of-its-kind high-speed centrifuge and magnetic stirrer in one unit. This design innovation enables... Read more

Neogen launches water-based aflatoxin screening test

CONTACT: Mary Gadola, Neogen Corporation, 517/372-9200 LANSING, Mich., Sept. 24, 2018 — Neogen has developed the first screening test for aflatoxin that uses only a water-based solution for extraction. Neogen’s new Reveal® MAX for Aflatoxin can accurately screen corn and wheat samples at 20 parts per billion (ppb) of aflatoxin in only 3 minutes. Results produced on the simple... Read more

Tecan successfully completes the acquisition of NuGEN Technologies

Männedorf, Switzerland, September 3, 2018 – The Tecan Group (SIX Swiss Exchange: TECN) announced today that it has successfully completed the acquisition of NuGEN Technologies, Inc. (NuGEN) on August 31, 2018. On August 16, 2018, Tecan announced the acquisition of US-based NuGEN to further expand Tecan’s dedicated solutions offering into the new market segment of next-generation... Read more

Smiths Detection secures multiple contracts to deliver enhanced detection solutions and bolster China’s security measures

BEIJING — 21 Sep 2018 Smiths Detection expands number of CAAC certified solutions to six, boosting threat detection capabilities in China Smiths Detection, a global leader in threat detection and screening technologies, today announced a number of recent wins in China, including the sale of 151 IONSCAN 600, which will be deployed across Chongqing Jiangbei International Airport, Qingdao Liuting... Read more

Smiths Detection agrees first proof of concept with customs administration of the Netherlands

LONDON — 19 Sep 2018 Smiths Detection, a global leader in threat detection and screening technologies, today announced that it has agreed to prepare the first proof-of-concept with the Customs Administration of the Netherlands for CORSYS, Smiths Detection’s pioneering enterprise-level security command centre. Announced in November 2017, CORSYS is Smiths Detection’s secure, cloud-based, digital ecosystem that integrates... Read more

Paragon Genomics Launches ParagonDesigner™ Online Tool That Makes It Easy To Design Custom CleanPlex® NGS Assays

  –Custom NGS Panels for Illumina and Ion Torrent Platforms Use Paragon Genomics’ CleanPlex® Technology that Enables Interrogation of a Large Number of Targets in a Single Assay– –Complementary Expert Support Is Available to All Customers and Custom NGS Panels are Delivered in Just 2-4 Weeks– HAYWARD, Calif., Sept. 20, 2018 /PRNewswire/ — Paragon Genomics, Inc. today... Read more

Early Access to IsoPlexis’ Single Cell Analytics Platform Enhances Cell Therapy Program at World-renowned Research and Treatment Center

IsoPlexis’ groundbreaking platform has been shown in key studies to predict patient response to cell therapy The IsoLight® platform: • profiles responses at the single cell level enabling researchers to generate a precise functional patient signature to help predict and understand complex patient response to cancer immunotherapies • advances high-need areas of cell therapy research,... Read more

Anton Paar ShapeTec upgrades machinery

2018-09-19 | Corporate Anton Paar ShapeTec in Wunschuh near Graz (Austria) is currently in high demand for contract manufacturing of high-precision metal parts. So it was apparent to expand the machinery and production capacities. Recently, a 5-axis milling machine and a turn-mill center went into service. Another new turn-mill center has been in operation since early... Read more